Physician profile
Donovan Mabe
NPI 1477815710
$11,847.03
in general payments reported to CMS, 2019-2025
17 companies · $11K in 2025
The $11K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $275 · 2024: $770 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,577 · Food and Beverage: $2,052 · Travel and Lodging: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,577.33 |
| Food and Beverage | $2,051.76 |
| Travel and Lodging | $1,217.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,734.93 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $681.52 | 2023-2025 | Tezspire, Airsupra, Tagrisso |
| Glaxosmithkline, LLC. | $645.83 | 2023-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Mylan Specialty L.P. | $178.00 | 2023-2024 | Yupelri |
| Insmed, INC. | $143.56 | 2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $101.60 | 2024-2025 | Opsumit, Uptravi |
| Baxter Healthcare | $75.03 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Takeda Pharmaceuticals U.S.A., INC. | $57.11 | 2024-2025 | Glassia, Aralast |
| Verona Pharma, INC. | $34.88 | 2025 | Ohtuvayre |
| Csl Behring | $33.19 | 2025 | Hizentra |
| Viatris Specialty LLC | $31.81 | 2025 | Yupelri |
| Tactile Systems Technology INC | $30.78 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Inogen, INC. | $27.93 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $21.69 | 2024 | Dupixent |
| Genzyme Corporation | $18.99 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $15.79 | 2024 | Enhertu |
| Philips North America LLC | $14.39 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donovan Mabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.